Filed: 5/6/2024ACC: 0001104659-24-057096
📋 What this filing means
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 16 equity positions with a total reported market value of $1.08B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
16
Positions
$1.08B
Total AUM (reported)
65.84M
Total Shares
Allocation by class
COMMON STOCK$1.08B100.0%
Portfolio Concentration
Top 3$586.26M54.1%
4–10$459.49M42.4%
11–25$37.81M3.5%
Top 3 weight
54.1%
Top 10 weight
96.5%
Voting Authority Distribution
Total shares with voting rights: 65.84M
Sole
Full voting authority
65.84M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole16
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings16
Rows:
Dyne Therapeutics, Inc.
SOLEShares8.02M
TypeSH
Market value$227.69M
21.01%
Sole
8.02M
Shared
0.00
None
0.00
Kymera Therapeutics, Inc.
SOLEShares5.38M
TypeSH
Market value$216.17M
19.95%
Sole
5.38M
Shared
0.00
None
0.00
Disc Medicine, Inc.
SOLEShares2.29M
TypeSH
Market value$142.40M
13.14%
Sole
2.29M
Shared
0.00
None
0.00
Day One Biopharmaceuticals, Inc.
SOLEShares6.43M
TypeSH
Market value$106.23M
9.80%
Sole
6.43M
Shared
0.00
None
0.00
Third Harmonic Bio, Inc.
SOLEShares10.91M
TypeSH
Market value$102.97M
9.50%
Sole
10.91M
Shared
0.00
None
0.00
Korro Bio, Inc.
SOLEShares1.12M
TypeSH
Market value$100.74M
9.30%
Sole
1.12M
Shared
0.00
None
0.00
Aerovate Therapeutics, Inc.
SOLEShares2.04M
TypeSH
Market value$60.30M
5.57%
Sole
2.04M
Shared
0.00
None
0.00
Q32 Bio, Inc.
SOLEShares2.09M
TypeSH
Market value$35.65M
3.29%
Sole
2.09M
Shared
0.00
None
0.00
Generation Bio, Co.
SOLEShares8.28M
TypeSH
Market value$33.70M
3.11%
Sole
8.28M
Shared
0.00
None
0.00
Vigil Neuroscience, Inc.
SOLEShares5.84M
TypeSH
Market value$19.90M
1.84%
Sole
5.84M
Shared
0.00
None
0.00
Replimune Group, Inc.
SOLEShares2.10M
TypeSH
Market value$17.14M
1.58%
Sole
2.10M
Shared
0.00
None
0.00
Ikena Oncology, Inc.
SOLEShares5.02M
TypeSH
Market value$7.13M
0.66%
Sole
5.02M
Shared
0.00
None
0.00
AvroBio, Inc.
SOLEShares4.54M
TypeSH
Market value$5.81M
0.54%
Sole
4.54M
Shared
0.00
None
0.00
Dianthus Therapeutics, Inc.
SOLEShares186.98K
TypeSH
Market value$5.61M
0.52%
Sole
186.98K
Shared
0.00
None
0.00
Xilio Therapeutics, Inc.
SOLEShares992.91K
TypeSH
Market value$1.07M
0.10%
Sole
992.91K
Shared
0.00
None
0.00
Spero Therapeutics, Inc.
SOLEShares607.61K
TypeSH
Market value$1.05M
0.10%
Sole
607.61K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Dyne Therapeutics, Inc.SOLE | Common Stock | 8.02M | SH | $227.69M 21.01% | 8.02M | 0.00 | 0.00 |
Kymera Therapeutics, Inc.SOLE | Common Stock | 5.38M | SH | $216.17M 19.95% | 5.38M | 0.00 | 0.00 |
Disc Medicine, Inc.SOLE | Common Stock | 2.29M | SH | $142.40M 13.14% | 2.29M | 0.00 | 0.00 |
Day One Biopharmaceuticals, Inc.SOLE | Common Stock | 6.43M | SH | $106.23M 9.80% | 6.43M | 0.00 | 0.00 |
Third Harmonic Bio, Inc.SOLE | Common Stock | 10.91M | SH | $102.97M 9.50% | 10.91M | 0.00 | 0.00 |
Korro Bio, Inc.SOLE | Common Stock | 1.12M | SH | $100.74M 9.30% | 1.12M | 0.00 | 0.00 |
Aerovate Therapeutics, Inc.SOLE | Common Stock | 2.04M | SH | $60.30M 5.57% | 2.04M | 0.00 | 0.00 |
Q32 Bio, Inc.SOLE | Common Stock | 2.09M | SH | $35.65M 3.29% | 2.09M | 0.00 | 0.00 |
Generation Bio, Co.SOLE | Common Stock | 8.28M | SH | $33.70M 3.11% | 8.28M | 0.00 | 0.00 |
Vigil Neuroscience, Inc.SOLE | Common Stock | 5.84M | SH | $19.90M 1.84% | 5.84M | 0.00 | 0.00 |
Replimune Group, Inc.SOLE | Common Stock | 2.10M | SH | $17.14M 1.58% | 2.10M | 0.00 | 0.00 |
Ikena Oncology, Inc.SOLE | Common Stock | 5.02M | SH | $7.13M 0.66% | 5.02M | 0.00 | 0.00 |
AvroBio, Inc.SOLE | Common Stock | 4.54M | SH | $5.81M 0.54% | 4.54M | 0.00 | 0.00 |
Dianthus Therapeutics, Inc.SOLE | Common Stock | 186.98K | SH | $5.61M 0.52% | 186.98K | 0.00 | 0.00 |
Xilio Therapeutics, Inc.SOLE | Common Stock | 992.91K | SH | $1.07M 0.10% | 992.91K | 0.00 | 0.00 |
Spero Therapeutics, Inc.SOLE | Common Stock | 607.61K | SH | $1.05M 0.10% | 607.61K | 0.00 | 0.00 |